Lv1
18 积分 2026-04-15 加入
Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models
13天前
已完结
High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models
13天前
已完结
Androgen receptor (AR) aberrations in castration-resistant prostate cancer
14天前
已完结
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer
19天前
已完结
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
19天前
已完结
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
20天前
已完结
Outcome Predictors of Radical Prostatectomy Followed by Adjuvant Androgen Deprivation in Patients with Clinical High Risk Prostate Cancer and pT3 Surgical Margin Positive Disease
20天前
已完结
Testosterone Recovery After Prolonged Androgen Suppression in Patients With Prostate Cancer
20天前
已完结
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
20天前
已完结
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer
20天前
已完结
皖公网安备34019202002308
